Structures by: Sultana N.
Total: 10
Structure 1 h03prr50
C42H32N2O4P2Pt
Dalton transactions (Cambridge, England : 2003) (2005) 16 2760-2765
a=8.47300(10)Å b=14.0020(2)Å c=30.4920(6)Å
α=90° β=91.1670(10)° γ=90°
Structure 2
C44H38P2Pt
Dalton transactions (Cambridge, England : 2003) (2005) 16 2760-2765
a=8.61800(10)Å b=13.9790(2)Å c=29.9090(4)Å
α=90.00° β=91.8530(10)° γ=90.00°
Structure 4 k03prr32
C61H49P2Pt
Dalton transactions (Cambridge, England : 2003) (2005) 16 2760-2765
a=16.3404(2)Å b=8.90130(10)Å c=32.8872(5)Å
α=90.00° β=95.9020(10)° γ=90.00°
5,7-Dihydroxy-6,2'-dimethoxyisoflavone
C17H14O6
Acta Crystallographica Section E (2005) 61, 6 o1812-o1814
a=13.6600(7)Å b=6.5247(3)Å c=17.5754(9)Å
α=90.00° β=111.7260(10)° γ=90.00°
Macrocyclic lactone
C14H20O4
Acta Crystallographica Section C (1998) 54, 6 789-790
a=11.667(3)Å b=7.292(2)Å c=15.275(3)Å
α=90.00° β=97.02(2)° γ=90.00°
3-Hydroxy-2,16-dioxatetracyclo[9.4.0.0^3,8^.1^1,8^]hexadecane
C14H22O3
Acta Crystallographica Section C (1998) 54, 9 1285-1287
a=21.558(4)Å b=6.5897(12)Å c=18.861(2)Å
α=90.00° β=111.891(10)° γ=90.00°
Gliclazide
C15H21N3O3S
Acta Crystallographica Section C (1999) 55, 1 74-75
a=10.8326(7)Å b=14.3281(15)Å c=10.976(3)Å
α=90.00° β=107.026(11)° γ=90.00°
Enoxacin
C15H17FN4O3,3H2O
Acta Crystallographica Section C (2004) 60, 4 o281-o283
a=13.618(3)Å b=7.2963(13)Å c=18.316(5)Å
α=90.00° β=108.282(12)° γ=90.00°
Clarithromycin Hydrochloride 3.5 Hydrate
C38H70NO131,Cl1,3.5H2O
Acta Crystallographica Section C (2000) 56, 9 e398-e399
a=14.409(2)Å b=16.489(3)Å c=19.267(3)Å
α=90.00° β=90.00° γ=90.00°
Pefloxacinium methanesulfonate 0.10 hydrate
C17H21FN3O3,CH3SO3,0.10H2O
Acta Crystallographica Section C (2000) 56, 7 910-912
a=8.111(3)Å b=10.0130(10)Å c=13.277(3)Å
α=101.220(10)° β=102.85(2)° γ=102.010(10)°